Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

Pediatrics

Volumn 126, Issue 1, 2010, Pages

  Klein, Nicola P ^a   Fireman, Bruce ^a   Yih, W Katherine ^b   Lewis, Edwin ^a   Kulldorff, Martin ^b   Ray, Paula ^a   Baxter, Roger ^a   Hambidge, Simon ^a   Nordin, James ^c   Naleway, Allison ^a   Belongia, Edward A ^d   Lieu, Tracy ^b   Baggs, James ^e   Weintraub, Eric ^e  

^a KAISER PERMANENTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d MARSHFIELD CLINIC   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Fever; Measles; Seizures; Vaccine; Varicella

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CHICKENPOX; CHILD; DRUG SAFETY; FEBRILE CONVULSION; FEVER; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RUBELLA; SEIZURE; VACCINATION;

AGE DISTRIBUTION; CHICKENPOX VACCINE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RETROSPECTIVE STUDIES; SEIZURES, FEBRILE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIME FACTORS; VACCINATION; VACCINES, COMBINED;

EID: 77952632479     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-0665     Document Type: Article

References (21)

1. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics. 1991;88(5):881-885
2. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345(8949):567-569
3. Barlow WE, Davis RL, Glasser JW, et al; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661
4. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA. 2004;292(3):351-357
5. Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005;24(8):665-669 (Pubitemid 41140946)
6. Lieberman JM, Williams WR, Miller JM, et al; Consistency Lot Study Group for ProQuad. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Pediatr Infect Dis J. 2006;25(7):615-622
7. Shinefield H, Black S, Thear M, et al; 013 Study Group for ProQuad. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Pediatr Infect Dis J. 2006;25(4):287-292
8. Lieu TA, Kulldorff M, Davis RL, et al; Vaccine Safety Datalink Rapid Cycle Analysis Team. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 suppl 2):S89-S95
9. Yih WK, Nordin JD, Kulldorff M, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009;27(32):4257-4262
10. Belongia EA, Irving SA, Shui IM, et al; Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1-5
11. Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Available at: www.populationmedicine.org/content/docs/maxSPRTsubm.pdf. Accessed July 9, 2009
12. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep. 2008;57(10):258-260
13. Kulldorff M. A spatial scan statistic. Commun Stat Theory Methods. 1997;26(6):1481-1496
14. Kulldorff M; Information Management Services Inc. SaTScan v8.0 ed: Software for the Spatial and Space-Time Scan Statistics. Boston, MA: Information Management Services Inc; 2009. Available at: www.satscan.org.
15. Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine. 2009;27(34):4656-4661
16. American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK, Baker C, Kimberlin D, Long S, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:560-569
17. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656
18. Davis RL, Marcuse E, Black S, et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics. 1997;100(5):767-771
19. Shui IM, Shi P, Dutta-Linn MM, et al; Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39):5307-5312
20. Centers for Disease Control and Prevention. CDC vaccine price list. Available at: www.cdc.gov/vaccines/programs/vfc/cdc-vacprice- list.htm. Accessed April 19, 2010
21. Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-3):1-12